MedTrace Logo

Urica Cor Intervention (URICORI) Trial

NCT04459936 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-05-26

No results posted yet for this study

Summary

The objective of the Urica Cor Intervention (URICORI) trial is to evaluate the effectiveness of a one-year, intervention of modifiable risk factors for CVD administered in a rheumatology outpatient clinical setting, compared with conventional treatment for modifiable risk factors for CVD in people with gout.

Conditions

Interventions

OTHER

URICORI

Treatment for cardiovascular risk factors according to national guideline administered at the department of Rheumatology

OTHER

CONTROL

Treatment for cardiovascular risk factors according to national guideline administered at the General Practitioner

Sponsors & Collaborators

  • Odense University Hospital

    collaborator OTHER

  • Frederiksberg University Hospital

    collaborator OTHER

  • Oak Foundation

    collaborator OTHER

  • The Danish Rheumatism Association

    collaborator OTHER

  • Region of Southern Denmark

    collaborator OTHER

  • University of Southern Denmark

    collaborator OTHER

  • Torkell Ellingsen

    lead OTHER

Principal Investigators

  • Melanie Morillon, MD · Odense University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-24
Primary Completion
2022-02-01
Completion
2022-02-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04459936 on ClinicalTrials.gov